Evonik to continue “growth strategy” in 2015

Essen, Germany – Evonik Industries AG has announced its financial results for the year ending 31 Dec 2014, stating that its profits were down 1 percent while its sales showed a meagre rise of 2 percent.

Sales at the German speciality chemical company reached €12.9 billion in 2014, while its adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) fell to €1.9 billion.

Evonik’s sales in speciality chemical’s segment was on a par with 2013, at €1,059 billion, while the segment’s adjusted EBITDA showed a 3-percent year-on-year declineto €95 million in 2014.

Evonik, however, has announced that holds an optimistic outlook for 2015, expecting to report slightly higher sales and a slightly higher adjusted earnings compared to 2014.

Klaus Engel, chairman of the executive board of Evonik also announced that the company intended to continue its growth strategy.

In 2014, Evonik invested €1.1 billion in new production facilities, including around €420 million at its German sites.

In September 2014. Evonik opened a new 20,000-tonne expansion at its precipitated silica site in Chester, Pennsylvania, while announcing a new investment, in the single-digit million euro range, in silica capacity expansion in Ako, Japan.

The expansions are part of Evonik’s initiative to increase world-wide capacities for precipitated silica by 30 percent.